Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych CASC / OSCEAddiction psychiatry — cannabis and psychosis

Psych CASC / OSCE · Addiction psychiatry — cannabis and psychosis

Explain cannabis and psychosis to parents — CASC communication station

MRCPsych/FRANZCP-style communication station: dual formulation, potency risk, parallel treatment, SIP conversion honesty, non-moralising cannabis counselling, vocational hope.

communication2 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
Parents of a 19-year-old with cannabis-associated first-episode psychosis want plain-language answers on causation, medication, stopping cannabis, CBD, university, and whether this is lifelong schizophrenia.

Station brief

Format. Communication station, approximately 7–10 minutes active time after reading. You are the psychiatry registrar in the early intervention / dual-diagnosis clinic. [1]

Candidate instructions. Explain the working dual diagnosis (psychosis plus cannabis use), discuss what is known about high-THC risk, outline medical checks and treatment (medication and psychosocial cannabis help), address CBD myths, discuss university, and explain why follow-up matters even if symptoms improve after stopping. Check understanding. The examiner plays both parents. [1][2]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this CASC / OSCE. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Di Forti M, Quattrone D, Freeman TP, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study Lancet Psychiatry, 2019.PMID 30902669
  2. [2]Starzer MSK, Nordentoft M, Hjorthøj C Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis Am J Psychiatry, 2018.PMID 29179576
  3. [3]Schoeler T, Petros N, Di Forti M, et al. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study Lancet Psychiatry, 2016.PMID 27567467
  4. [4]McGuire P, Robson P, Cubala WJ, et al. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial Am J Psychiatry, 2018.PMID 29241357
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplain CAMHS to adult transition plan — CASC communication stationChild and adolescent psychiatry — service interfaceNextExplain CBT-I and hypnotic taper for chronic insomnia disorder — CASC communication stationSpecialty psychiatry — sleep medicine interface